Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.

Plasmodium vivax is the major species of malaria parasite outside Africa. It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver. Medicines that target the erythrocytic stages of Plasmodium falciparum are also act...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Wells, T, Burrows, J, Baird, J
Materialtyp: Journal article
Språk:English
Publicerad: 2010
_version_ 1826285258208706560
author Wells, T
Burrows, J
Baird, J
author_facet Wells, T
Burrows, J
Baird, J
author_sort Wells, T
collection OXFORD
description Plasmodium vivax is the major species of malaria parasite outside Africa. It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver. Medicines that target the erythrocytic stages of Plasmodium falciparum are also active against P. vivax, except where these have been compromised by resistance. However, the only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine. This molecule has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment. New, safer and more-easily administered drugs are urgently needed, and this is a crucial gap in the broader malaria-elimination agenda. New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites. This search is urgent, given the time needed to develop a new medication.
first_indexed 2024-03-07T01:26:08Z
format Journal article
id oxford-uuid:920ce46b-b9ff-4e67-94c6-d4c4edecaaa9
institution University of Oxford
language English
last_indexed 2024-03-07T01:26:08Z
publishDate 2010
record_format dspace
spelling oxford-uuid:920ce46b-b9ff-4e67-94c6-d4c4edecaaa92022-03-26T23:22:45ZTargeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:920ce46b-b9ff-4e67-94c6-d4c4edecaaa9EnglishSymplectic Elements at Oxford2010Wells, TBurrows, JBaird, JPlasmodium vivax is the major species of malaria parasite outside Africa. It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver. Medicines that target the erythrocytic stages of Plasmodium falciparum are also active against P. vivax, except where these have been compromised by resistance. However, the only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine. This molecule has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment. New, safer and more-easily administered drugs are urgently needed, and this is a crucial gap in the broader malaria-elimination agenda. New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites. This search is urgent, given the time needed to develop a new medication.
spellingShingle Wells, T
Burrows, J
Baird, J
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
title Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
title_full Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
title_fullStr Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
title_full_unstemmed Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
title_short Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
title_sort targeting the hypnozoite reservoir of plasmodium vivax the hidden obstacle to malaria elimination
work_keys_str_mv AT wellst targetingthehypnozoitereservoirofplasmodiumvivaxthehiddenobstacletomalariaelimination
AT burrowsj targetingthehypnozoitereservoirofplasmodiumvivaxthehiddenobstacletomalariaelimination
AT bairdj targetingthehypnozoitereservoirofplasmodiumvivaxthehiddenobstacletomalariaelimination